Market Closed -
Nasdaq
04:00:00 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
12.73
USD
|
-1.47%
|
|
-1.01%
|
-10.98%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,285
|
872.9
|
377.2
|
231.4
|
336
|
302.5
|
-
|
-
|
Enterprise Value (EV)
1 |
1,285
|
872.9
|
377.2
|
231.4
|
336
|
302.5
|
302.5
|
302.5
|
P/E ratio
|
121
x
|
-1,498
x
|
-31.7
x
|
-12.9
x
|
11.6
x
|
23
x
|
14.4
x
|
9.61
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.78
x
|
4.66
x
|
1.81
x
|
0.94
x
|
1.22
x
|
1
x
|
0.89
x
|
0.79
x
|
EV / Revenue
|
6.78
x
|
4.66
x
|
1.81
x
|
0.94
x
|
1.22
x
|
1
x
|
0.89
x
|
0.79
x
|
EV / EBITDA
|
50.8
x
|
54.5
x
|
21.3
x
|
12.6
x
|
11.3
x
|
8.88
x
|
6.23
x
|
4.98
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
19,028
|
19,425
|
19,823
|
20,155
|
23,498
|
23,762
|
-
|
-
|
Reference price
2 |
67.51
|
44.94
|
19.03
|
11.48
|
14.30
|
12.73
|
12.73
|
12.73
|
Announcement Date
|
2/26/20
|
2/23/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
189.5
|
187.1
|
208.1
|
246.8
|
274.4
|
303
|
341.1
|
381.1
|
EBITDA
1 |
25.3
|
16.01
|
17.73
|
18.3
|
29.65
|
34.06
|
48.59
|
60.8
|
EBIT
1 |
11.65
|
-3.628
|
5.258
|
6.246
|
18.04
|
19.2
|
32.29
|
45.15
|
Operating Margin
|
6.15%
|
-1.94%
|
2.53%
|
2.53%
|
6.57%
|
6.34%
|
9.47%
|
11.85%
|
Earnings before Tax (EBT)
1 |
11.13
|
-2.261
|
-2.293
|
-15.47
|
15.77
|
19.78
|
32.69
|
45.55
|
Net income
1 |
10.97
|
-0.62
|
-11.81
|
-17.87
|
28.52
|
13.26
|
22.9
|
31.88
|
Net margin
|
5.79%
|
-0.33%
|
-5.68%
|
-7.24%
|
10.39%
|
4.38%
|
6.71%
|
8.36%
|
EPS
2 |
0.5600
|
-0.0300
|
-0.6000
|
-0.8900
|
1.230
|
0.5533
|
0.8825
|
1.325
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/26/20
|
2/23/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
61.73
|
47.98
|
59.64
|
65.26
|
73.9
|
58.85
|
68.34
|
69.59
|
77.65
|
61.09
|
72.81
|
79.07
|
89.98
|
69.12
|
82.31
|
EBITDA
1 |
9.487
|
-2.612
|
1.669
|
7.163
|
12.08
|
0.506
|
6.076
|
7.696
|
15.38
|
1.033
|
8.338
|
9.562
|
14.69
|
5.074
|
11.64
|
EBIT
1 |
6.438
|
-5.391
|
-4.087
|
-1.62
|
9.52
|
-2.187
|
2.058
|
7.989
|
11.8
|
-1.7
|
4.333
|
5.95
|
11.47
|
0.3997
|
7.478
|
Operating Margin
|
10.43%
|
-11.24%
|
-6.85%
|
-2.48%
|
12.88%
|
-3.72%
|
3.01%
|
11.48%
|
15.2%
|
-2.78%
|
5.95%
|
7.52%
|
12.75%
|
0.58%
|
9.08%
|
Earnings before Tax (EBT)
1 |
3.388
|
-15.36
|
-4.66
|
-2.356
|
6.9
|
-4.799
|
1.22
|
7.585
|
11.76
|
-2.809
|
4.4
|
6.05
|
11.54
|
0.4997
|
7.578
|
Net income
1 |
-7.495
|
-15.57
|
-4.64
|
-2.279
|
4.621
|
-1.886
|
-0.1
|
22.3
|
8.202
|
-2.209
|
3.12
|
4.251
|
8.126
|
0.3397
|
5.281
|
Net margin
|
-12.14%
|
-32.45%
|
-7.78%
|
-3.49%
|
6.25%
|
-3.2%
|
-0.15%
|
32.05%
|
10.56%
|
-3.62%
|
4.29%
|
5.38%
|
9.03%
|
0.49%
|
6.42%
|
EPS
2 |
-0.3800
|
-0.7800
|
-0.2300
|
-0.1100
|
0.2300
|
-0.0900
|
-
|
0.9400
|
0.3500
|
-0.0900
|
0.1150
|
0.1825
|
0.3450
|
-0.0100
|
0.2025
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/22/22
|
5/2/22
|
8/1/22
|
11/7/22
|
2/21/23
|
5/8/23
|
8/7/23
|
11/6/23
|
2/20/24
|
5/6/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
10.9%
|
-
|
-9.34%
|
-
|
-
|
14.7%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/26/20
|
2/23/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Last Close Price
12.73
USD Average target price
20.67
USD Spread / Average Target +62.35% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.98% | 302M | | +75.69% | 12.57B | | -24.68% | 7.34B | | +6.22% | 6.61B | | +12.58% | 5.39B | | +26.90% | 4.53B | | -21.14% | 3.91B | | -22.99% | 2.91B | | +47.42% | 2.37B | | -0.37% | 2B |
Medical Equipment
|